SOUTH SAN FRANCISCO, Calif., Jan. 15, 2016 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA) today announced the appointment of Kelly Bryant as senior director, business development based in CLSA's South San Francisco office. Bryant is responsible for designing and delivering the best in class member experience that CLSA members have come to expect. Bryant will spearhead member development programs and serves as the Bay Area's trusted resource for maximizing CLSA's membership privileges. As the nation's largest statewide life sciences public policy, advocacy and business solutions organization, CLSA serves over 750 life sciences organizations across California.
Bryant will play a key role in business development and forging partnerships throughout the state, while implementing strategic programs that produce premium member value. Additionally, Bryant will serve as an ambassador for CLSA, building industry wide awareness of the CLSA member experience.
"As CLSA continues to grow and support California's life sciences economy and community, we sought an industry veteran to help meet and exceed the member goals and business objectives of our organization," said CLSA President and CEO Sara Radcliffe. "Given Kelly's extensive background and leadership qualities, CLSA members will greatly benefit from this dynamic asset."
Bryant's track record spans from the medical device, technical genomic and health sciences sectors including stints at Ceres, MDVIP (a Proctor & Gamble Co.), and Boston Scientific.
"Kelly embodies exactly what CLSA members expect when they join the most prestigious network of life sciences pioneers, risk takers and thought leaders," said Holly Smithson, Senior Vice President, Business Strategy and Development. "Kelly is a dynamic professional and committed to brokering member successes at all levels. I expect CLSA members may well enjoy her X factor."
Headshot available upon request.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Contact:
Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 



